Targeted Growth of TCF7-Positive Tumor-Reactive T Cells Offers New Hope for Ovarian Cancer
A groundbreaking study recently published in Science China Life Sciences unveils critical advances in tumor-infiltrating lymphocyte (TIL) therapy for ovarian ...